SHERMAN MARK ANDREW — SEC insider filings

SEC reporting owner CIK 1256708. 24 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2020-11-03 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Dolby Laboratories, Inc. (DLB)EVP, Gen. Counsel & Secretary24—41 legs · 271,611 sh · $22,679,02271

Insider filings — SHERMAN MARK ANDREW

FiledFormIssuerReported transactionsSource
2026-09-174Dolby Laboratories, Inc. (DLB)Grant/award (A): 48,076 @ $0EDGAR
2025-12-174Dolby Laboratories, Inc. (DLB)Grant/award (A): 25,633 @ $0 · Option exercise (M): 5,915 @ $0 · Tax withholding (F): 9,252 @ $67.54 · Tax withholding (F): 2,530 @ $66.62 · Sale (S): 6,738 @ $66.58 · Sale (S): 2,371 @ $67.17 · +4 moreEDGAR
2025-12-034Dolby Laboratories, Inc. (DLB)Option exercise (M): 4,500 @ $64.60 · Sale (S): 4,500 @ $67.56 · Option exercise (M): 4,500 (derivative) @ $0EDGAR
2025-06-064Dolby Laboratories, Inc. (DLB)Option exercise (M): 15,000 @ $64.60 · Sale (S): 15,000 @ $75.02 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-06-034Dolby Laboratories, Inc. (DLB)Sale (S): 350 @ $74.97EDGAR
2025-02-034Dolby Laboratories, Inc. (DLB)Option exercise (M): 40,000 @ $62.32 · Sale (S): 15,000 @ $83 · Sale (S): 25,000 @ $86.00 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2024-12-184Dolby Laboratories, Inc. (DLB)Grant/award (A): 20,085 @ $0 · Option exercise (M): 5,192 @ $0 · Tax withholding (F): 8,867 @ $79.18 · Sale (S): 4,625 @ $77.83 · Sale (S): 7,713 @ $78.22 · Grant/award (A): 10,042 (derivative) @ $0 · +2 moreEDGAR
2024-05-304Dolby Laboratories, Inc. (DLB)Option exercise (M): 1,998 @ $62.32 · Sale (S): 2,283 @ $79.62 · Option exercise (M): 1,998 (derivative) @ $0EDGAR
2023-12-194Dolby Laboratories, Inc. (DLB)Grant/award (A): 16,726 @ $0 · Option exercise (M): 5,738 @ $0 · Tax withholding (F): 8,713 @ $88.60 · Tax withholding (F): 1,637 @ $87.49 · Sale (S): 8,856 @ $86.19 · Sale (S): 1,663 @ $86.01 · +3 moreEDGAR
2023-07-144Dolby Laboratories, Inc. (DLB)Option exercise (M): 21,000 @ $62.32 · Sale (S): 21,000 @ $89 · Option exercise (M): 21,000 (derivative) @ $0EDGAR
2023-05-104Dolby Laboratories, Inc. (DLB)Option exercise (M): 11,118 @ $45.50 · Option exercise (M): 3,882 @ $62.32 · Sale (S): 12,820 @ $83.47 · Sale (S): 2,180 @ $84.35 · Option exercise (M): 11,118 (derivative) @ $0 · Option exercise (M): 3,882 (derivative) @ $0EDGAR
2023-02-074Dolby Laboratories, Inc. (DLB)Option exercise (M): 12,000 @ $45.50 · Sale (S): 12,000 @ $85 · Sale (S): 2,413 @ $83.65 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2022-12-224Dolby Laboratories, Inc. (DLB)Sale (S): 1,638 @ $68.09EDGAR
2022-12-194Dolby Laboratories, Inc. (DLB)Tax withholding (F): 2,510 @ $73.17 · Grant/award (A): 18,299 @ $0 · Option exercise (M): 5,344 @ $0 · Tax withholding (F): 3,574 @ $71.07 · Sale (S): 2,334 @ $70.66 · Tax withholding (F): 1,612 @ $70.80 · +5 moreEDGAR
2022-02-094Dolby Laboratories, Inc. (DLB)Sale (S): 1,798 @ $77.23EDGAR
2021-12-204Dolby Laboratories, Inc. (DLB)Tax withholding (F): 1,612 @ $92 · Sale (S): 1,663 @ $90.17 · Sale (S): 1,638 @ $90.69EDGAR
2021-12-164Dolby Laboratories, Inc. (DLB)Tax withholding (F): 3,506 @ $90.55 · Grant/award (A): 14,757 @ $0 · Tax withholding (F): 1,637 @ $91.80 · Sale (S): 1,432 @ $90.97 · Sale (S): 332 @ $91.90 · Grant/award (A): 7,378 (derivative) @ $0 · +1 moreEDGAR
2021-03-034Dolby Laboratories, Inc. (DLB)Option exercise (M): 13,000 @ $45.50 · Sale (S): 13,000 @ $100 · Option exercise (M): 13,000 (derivative) @ $0EDGAR
2021-02-174Dolby Laboratories, Inc. (DLB)Option exercise (M): 13,000 @ $45.50 · Sale (S): 13,000 @ $95 · Option exercise (M): 13,000 (derivative) @ $0EDGAR
2021-02-084Dolby Laboratories, Inc. (DLB)Sale (S): 1,436 @ $91.68 · Sale (S): 227 @ $92.23 · Option exercise (M): 2,882 @ $45.50 · Sale (S): 2,707 @ $91.48 · Sale (S): 175 @ $92.23 · Option exercise (M): 23,118 @ $45.50 · +4 moreEDGAR
2020-12-214Dolby Laboratories, Inc. (DLB)Tax withholding (F): 1,612 @ $91.03 · Sale (S): 1,638 @ $91.96EDGAR
2020-12-174Dolby Laboratories, Inc. (DLB)Tax withholding (F): 3,348 @ $90.86 · Grant/award (A): 14,272 @ $0 · Tax withholding (F): 1,637 @ $92.08 · Sale (S): 3,065 @ $90.62 · Sale (S): 337 @ $91.66 · Grant/award (A): 7,136 (derivative) @ $0 · +1 moreEDGAR
2020-11-054Dolby Laboratories, Inc. (DLB)Option exercise (M): 23,418 @ $42.98 · Sale (S): 23,418 @ $80.00 · Option exercise (M): 1,582 @ $45.50 · Sale (S): 1,582 @ $80.00 · Option exercise (M): 23,418 (derivative) @ $0 · Option exercise (M): 1,582 (derivative) @ $0EDGAR
2020-11-034Dolby Laboratories, Inc. (DLB)Option exercise (M): 25,000 @ $42.98 · Sale (S): 25,000 @ $76.00 · Option exercise (M): 25,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1256708 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs